2010版中国药典英文2012

2010版中国药典中国药典2010年版名称：《中华人民共和国药典》中国药典2010版作者：国家药典委员会出版社：中国医药科技出版社2010年10月出版开本：16开精装册数：全三卷定价：1498 元优惠价：980 元读者服务部→发行部：,内容简介：2010年版药典的鲜明特色：更新与淘汰并举、收载品种大幅增加。

药品检测项目和检测方法增加、标准提高，因而在药品安全性和质量可控性方面有更高、更多、更大提升。

二部中采用高效液相色谱法进行含量测定或用于有关物质检查的品种有近千个，系统适用性要求也更为合理，个别品种采用了分离效能更高的离子色谱法，检测器使用种类也更加多样。

中药标准有突破和创新，尤其在过去比较薄弱的中药材和中药饮片标准的新增和修订方面，如本版《中国药典》一部中动物药蛇类、植物药川贝母等，都采用了PCR检测方法。

新版药典在凡例、品种的标准要求、附录的制剂通则等方面均有较大的变化和进步。

在广泛吸取国内外先进技术和实验方法的基础上，附录内容与目前国际对药品质量控制的方法和技术力求一致，进一步发挥《中国药典》的国际影响力。

新版药典在坚持科学、实用、规范、药品安全性、质量可控性和标准先进性的原则下，力求覆盖国家基本药物目录品种和社会医疗保险报销药品目录品种。

顶尖专家扛鼎之作。

本版《中国药典》是在第九届药典委员会的精心组织下，聘请全国医药行业323位一流专家、投入巨额资金、历时两年编制而成,集中体现了当前我国药品标准工作的最新发展成果。

《中国药典》是国家监督管理药品质量的法定技术标准。

2010年版《中国药典》分为三部出版，一部为中药，二部为化学药，三部为生物制品。

各部内容主要包括凡例、标准正文和附录三部分，其中附录由制剂通则、通用检测方法、指导原则及索引等内容构成。

药典二部收载化学药品、抗生素、生化药品、放射性药品以及药用辅料等。

药典三部收载生物制品。

新版药典在凡例、品种的标准要求、附录的制剂通则和检验方法等方面均有较大的改进和发展，特别是对药品的安全性、有效性和质量可控性方面尤为重视。

最完整、最清晰的2010版中国药典(共三部)费尽千辛万苦，终于弄来了最完整、最清晰的2010版中国药典，效果堪比正版原书。

绝对完整，绝对清晰的2010版中国药典pdf版，共三部，还包括了2010版中国药典勘误表。

内容比较大，三部一共超过440M，大家可以自己去淘宝，下载需要耐心哦。

最完整、最清晰的2010版中国药典(共三部)原文地址：/forum-viewthread-tid-19984-fromuid-5.html主要内容：（1）《中国药典》2010年版1部.pdf（2）《中国药典》2010年版2部.pdf（3）《中国药典》2010年版3部.pdf（4）中国药典2010版1部附录.pdf（5）2010版中国药典一部勘误表.pdf（6）2010版中国药典二部误表.pdf（7）2010版中国药典三部勘误表.pdf2010版中国药典（中药材部分）目录一枝黄花(p3) ................................................................................................... 错误!未定义书签。

丁公藤(p3) ....................................................................................................... 错误!未定义书签。

丁香(p4) ........................................................................................................... 错误!未定义书签。

八角茴香(p4) ................................................................................................... 错误!未定义书签。

2010年药典第三部英文回答：In 2010, the third edition of the Pharmacopoeia was published, which set forth the requirements and standardsfor pharmaceutical substances and preparations. Thisedition aimed to ensure the quality, safety, and efficacyof medicines used in the healthcare industry. It included guidelines for the identification, testing, and control of active pharmaceutical ingredients, as well as theformulation and labeling of finished products.The Pharmacopoeia serves as a vital reference for healthcare professionals, including pharmacists, physicians, and regulatory authorities. It provides them with comprehensive information on the quality and standards of medicines, allowing them to make informed decisions regarding patient care. For example, if a physician prescribes a particular medication, they can consult the Pharmacopoeia to ensure that the product meets the requiredspecifications and is safe for use.One of the key features of the 2010 edition is the inclusion of monographs, which provide detaileddescriptions and specifications for individual drugs ordrug classes. These monographs cover a wide range of topics, including the physical and chemical properties of the drug, the recommended dosage forms and strengths, and the analytical methods for testing its quality. By followingthe monographs, pharmaceutical manufacturers can ensurethat their products are consistent with the established standards.Moreover, the Pharmacopoeia also addresses the issue of impurities in pharmaceutical substances. It sets limits for impurities, such as residual solvents, heavy metals, and microbial contaminants, to ensure that medicines are free from potentially harmful substances. These limits are based on scientific evidence and are designed to protect patient safety. For example, if a medication contains excessive levels of a particular impurity, it may pose a risk to the patient's health. The Pharmacopoeia helps to prevent suchsituations by providing guidelines for testing and controlling impurities.In addition to the standards for pharmaceutical substances, the Pharmacopoeia also includes guidelines for the formulation and labeling of finished products. These guidelines ensure that medicines are formulated in a way that maximizes their stability, efficacy, and safety. For example, the Pharmacopoeia may specify the acceptable range of pH for a particular oral solution to ensure itsstability over time. It may also provide labeling requirements, such as the mandatory inclusion of certain warnings or precautions on the product packaging.中文回答：2010年，第三版药典出版，规定了药物物质和制剂的要求和标准。

2010版药典介绍2010版药典（Pharmacopoeia of the People’s Republic of China, 2010 Edition）是中华人民共和国的一项法定药典，由中国食品药品监督管理局主管，于2010年首次正式发布。

药典是规定和标准化药物质量的权威性文献，对于保证药品的质量和安全至关重要。

每个国家都有自己的药典，以提供关于药物标准、药物检测及质量控制的指导。

药典发展历程自从2000年第一版药典发布以来，每隔十年，中国都会出版一次新版的药典，以适应药物和医疗行业的发展需求。

2010版药典在追求高质量药品的同时，也考虑到了国际药品质量要求的变化。

它包含了中国传统药材和西药等各类药品的质量标准。

药典的内容2010版药典详细描述了每种药品的质量标准，包括药物成分、理化性质、检测方法、用法用量和质量控制等。

药典的目的是确保药物的质量、有效性和安全性，从而保护患者的健康。

药典中还包含了一些药物鉴别和检测的基本原则和指导，以及药品生产和质量控制的规范要求。

药典在保障药品质量中的作用药典是确保药品质量的重要工具。

它为药物生产企业提供了明确的质量标准，帮助企业进行药品质量的控制和管理。

同时，药典还为药物检验机构提供了参考标准和检验方法，确保对药品质量进行准确和有效的检测。

此外，药典还为医疗机构提供了选择合格药品的参考依据，保证患者用药的安全性和有效性。

药典的重要性药典的制定和实施对于维护药品质量、保障患者用药安全具有重要意义。

药典是一个国家药品质量管理体系的重要组成部分，发挥着规范药品生产和流通环节的功能。

它对于推动药品质量的提升、促进药物研发和创新以及保护公众的健康起着至关重要的作用。

结论2010版药典是中华人民共和国发布的一项法定药典，是保障药品质量和保护患者用药安全的重要工具。

药典规定了药品的质量标准，对于药物的生产、检验和使用提供了指导。

药典的制定和实施对于提高药品质量、推动医药行业发展、保护公众健康具有重要意义。

中国药典2010版(一部)部分标准商榷张南平，肖新月(中国药品生物制品检定所，北京100050)Discussion about the problem of Chinese Pharmacopoeia 2010 EditionZHANG Nan-ping,XIAO Xin-yue(The National Institute for the Control of Pharmaceutical and Biological Products 100050 Beijing )2010年版中国药典于2010年10月1日开始正式执行，标准中所有内容的准确性、规范性直接关系到相关药品检验工作的严肃性、公正性和可操作性。

本文作者将研读新版中国药典一部时发现的药材和饮片部分正文及相关附录中的一些问题，依据生物学基本概念和知识，结合多年从事中药材检验与标准研究积累的经验进行了探讨，并提出修订建议，希望有助于中国药典的完善与提高。

具体内容分述如下：1.前言倒数第13行“桃仁、杏仁等新增黄曲霉毒素检测”。

应删去“、杏仁”。

因为正文杏仁项下无黄曲霉毒素检测项目。

2.三白草(第12页)项下载有“【性状】…基出脉5条。

”据《中国植物志》记载，本植物叶片有基出脉5～7条。

故建议改为“【性状】……基出脉5～7条。

”3.大叶紫珠(第18页)项下收载药用部位为干燥叶或带叶嫩枝；拉丁药名为“CALLICARPAE MACROPHYLLAE FOLIUM”。

鉴于拉丁药名构成中缺带叶嫩枝的表述，建议应修正为“CALLICARPAE MACROPHYLLAE RAMULUS ET FOLIUM”。

4.山香圆叶(第28页)项下载有“本品为省沽油科山香圆Turpinia arguta Seem.的干燥叶。

”“【鉴别】(1)本品横切面：…中柱鞘纤维束排列成不连续的环。

”因为叶是没有中柱鞘的，所以也就没有中柱鞘纤维束。

植物学文献将此处称为维管束鞘，一般由厚壁的纤维或薄壁细胞组成，建议改成“【鉴别】(1)本品横切面：…维管束鞘纤维束排列成不连续的环。

SDA Order #79Order by Ministry of Health of the People’s Republic of ChinaPublished on February 12, 2011No. 79Good Manufacturing Practice for Pharmaceutical Products (Amended in 2010) has passed by Affairs Meeting on October 19, 2010. This Regulation is now published and shall be effective from March 1, 2011.Director Zhu CHENJanuary 17, 2011Chapter 1 General ProvisionsArticle 1 In order to standardize good manufacturing for pharmaceutical products, this Regulation is enacted in accordance with the “Drug Administration Law of the People’s Republic of China” and “The Regulation on the Implementation of Drug Administration Law of the People’s Republic of China”.Article 2 A p harmaceutical enterprise shall establish pharmaceutical goods’ quality control system. The system shall contain all factors which may affect the quality of pharmaceutical goods, including all organized and planned activities ensuring pharmaceutical goods’ quality in accordance with intending purpose.Article 3 This Regulation is part of quality control system, is basic requirement for manufacturing and quality control of pharmaceutical products. This Regulation aims to reduce the risks in pharmaceutical g oods’ manufacturing process at its maximum, such as pollution,cross pollution and confusion, mistake, ensure for continuous stably manufacturing pharmaceutical goods in accordance with intending purpose and registered requirements.Article 4 The enterprise shall obey this Regulation strictly, insist on honesty and keep faith, prohibit any ostensible and spurious activities.Chapter 2 Quality ControlSection 1 PrincipleArticle 5 The enterprise shall establish quality target in accordance with pharmaceutical goods’ quality control requirements, carry out all requirements related to safety, effective and quality control into the process of pharmaceutical goods’ manufacturing, control and products’ discharging, storag e, delivering, ensure all pharmaceutical goods are produced in accordance with intending purpose and registered requirements.Article 6 Senior administrator in enterprise shall ensure the achievement of intending quality target. Personnel in different levels and provider, dealer shall participate in and take each responsibility.Article 7 The enterprise shall equip adequate personnel, workshop, establishment and equipment in accordance with requirements, and provide essential condition for achieving quality target.Section 2 Quality GuaranteeArticle 8 Quality guarantee is a part of quality control system. The enterprise must establish quality guarantee system, and establish integrate document system at the same time, in order to ensure the system’s e ffective running.Article 9 Quality guarantee system shall ensure the following:I. Represent the requirements of this Regulation in pharmaceutical goods’ design anddevelopment.II. In accordance with the requirements of this Regulation in manufacturing management and quality control activities;III. Specific management responsibility;IV. Exact stocked and used raw material and wrapper;V. Effective control in semi-finished product;VI. Implement of confirmation and validation;VII. Manufacture, examine, inspect and double examined according to rules strictly; VIII. Each batch of products shall only discharge after quality authorizing person’s approval;IX. Applicable measures to ensure pharmaceutical goods’ quality during the process of storage, delivering and all succedent operation process;X. According to self-examine rules, examine and evaluate the validity and applicability of the quality guarantee system quality.Article 10 Basic requirements of pharmaceutical goods’ manufacture quality management: I. Frame manufacturing technique, systemic review and demonstrate it couldcontinuous stably manufacturing products in accordance with requirements;II. Manufacturing technique and its important changes shall be validated;III. Equip all required resources, include, but not limited the following:1. Hold applicable qualification and the eligible trained personnel;2. Adequate workshop and space;3. Applicable equipment and maintain guarantee;4. Accurate raw material, wrapper and label;5. Approved technique rules and operate rules;6. Applicable storage and freight condition.IV. Use accurate and easy understand language to frame operate rules;V. The operate person could accurate operate according to operate rules after training;VI. The whole manufacture process shall be recorded. The windage shall be researched and be recorded;VII. Batch record and delivering record shall be traced back to the whole history of the batch of products, and the records shall be saved appropriately and be easy consult; VIII. Reduce the quality risk during the pharmaceutical goods’ delivering process;IX. Establish pharmaceutical goods’recall system, and ensure any batch delivered and sold products could be recalled;X. Survey the reasons leading to pharmaceutical goods’complaints and quality objections, take measures to prevent similar quality objections.Section 3 Quality ControlArticle 11 Quality control includes corresponding organization, document system and sampling, test and so on, to ensure material or products finish necessary examination before delivering, and to verify its quality is in accordance with the requirements.Article 12 Basic requirements of quality control:I. Equip applicable establishment, equipment, instrument and trained personnel to effective and reliable finish all related quality control activities;II. Have approved operate rules, which used to sampling, examine, inspect raw material, wrapper, semifinished product, bulk product and finished product and products’stability, monitor environment when necessary, to ensure the products is in accordance with the requirements of this Regulation;III. Authorized person shall sampling to raw material, wrapper, semifinished product, bulk product and finished product according to stated methods;IV. Inspect methods shall be confirmed and validated;V. Sampling, check, inspect shall be recorded, the windage shall be researched and be recorded;VI. Material, semifinished product, bulk product and finished product shall be checked and inspected according to quality standard and be recorded;VII. Material and packaged finished product shall have enough reserved samples so that necessary check or inspect shall be taken; except the finished product with too large package container, the reserved sample s’package shall be the same with the final package of the finished product.Section 4 Quality Risk ManagementArticle 13 Quality risk management is evaluate, control, communicate, audit system process to quality risk during the whole product life period, via the manner of foresee or review.Article 14 Quality risk shall evaluate according to science knowledge and experience in order to ensure products’ quality.Article 15 The method, measure, form take during the quality risk management process and the documents formed in the said process shall accommodate to the level of the existent risk.Chapter 3 Organization and PersonnelSection 1 PrincipleArticle 16 An enterprise shall establish management organization which accommodate to the pharmaceutical goods’ product and have its organization framework chart.The enterprise shall set up independent quality management department, which carries out the responsibilities of quality guarantee and quality control. The quality management department could set up quality guarantee department and quality control department respectively.Article 17 Quality management department shall take part in all activities relating to quality, and take responsibility to audit all documents relating to this Regulation. The personnel inquality management department shall not relegate his responsibility to the personnel in other department.Article 18 The enterprise shall be staffed by an appropriate number of management and technical personnel with appropriate qualification (including education background, training and practice experience), and the responsibilities of each department and each station shall be clarified. Station’s responsibility shall not be missed and cross responsibility shall be prescribed specifically. Responsibility taken by each person shall not be overfull.Every person shall clear and understand his own responsibilities, be familiar with the requirements related to his responsibilities, and accept necessary training, including pre-job training and on-job training.Article 19 Generally, one shall not relegate his responsibility to other person. If the responsibilities do need to be relegated, the one should relegate his responsibility to the designated person who has equivalent qualification.Section 2 Important PersonArticle 20 The important person shall be the full-time person of the enterprise, at least including the director of the enterprise, director of manufacturing management, director of quality management and authorized person of quality.Director of quality management and director of manufacturing management shall be independent of each other. Director of quality management and authorized person of quality shall not be independent of each other. Operation proceduress shall be established so that authorized person of quality could take his responsibility independently, with no interference from director of enterprise and other person.Article 21 Director of enterpriseDirector of enterprise is the main responsible person of pharmaceutical goods’ quality, who comprehensive responsible to the daily management of the enterprise. In order to ensure theenterprise complete quality target and manufacture pharmaceutical goods according to this Regulation, the director of enterprise shall take responsible for providing necessary resources, reasonable plan, organize and correspond to ensure the quality management department could take its responsibility independently.Article 22 Director of manufacturing managementI. Qualification:Director of manufacturing management shall at least have pharmacology or related specialty undergraduate education background (or secondary professional technical title or licensed pharmacist qualification), have at least three years’ pharmaceutical goods’ manufacturing and quality management experience, including at least one year’s pharmaceutical goods’manufacturing management experience, have taken part in professional knowledge training related to manufacturing products.II. Main responsibility:1. Manufacture and storage the pharmaceutical goods according to approvedtechnology procedure in order to ensure the quality of the pharmaceutical goods;2. Ensure every operation proceduress related to manufacturing operation areperformed strictly;3. Ensure batch production record and batch package record are audited by designatedperson and submitted to quality management department;4. Ensure the maintenance of workshop and equipment in order to preserve its goodworking condition;5. Ensure all kind of necessary validation work is completed;6. Ensure person related to manufacturing have been trained by pre-job training andon-job training, adjust training content according to actual demands.Article 23 Director of quality managementI. Qualification:Director of quality management shall at least have pharmacology or related specialty undergraduate education background (or secondary professional technical title or licensedpharmacist qualification), have at least five years’ pharmaceutical goods’ manufacturing and quality management experience, including at least one year’s pharmaceutical goods’ quality management experience, have taken part in professional knowledge training related to manufacturing products.II. Main responsibility:1. Ensure the raw material, wrapper, semifinished product, bulk product and finishedproduct are in accordance with the registered approved requirements and quality standard;2. Ensure the products are audited to batch record before delivering;3. Ensure necessary inspection is finished;4. Approve quality standard, sampling method, inspection method and other operationproceduress of quality management;5. Audit and approve all changes related to quality;6. Ensure all important windage and exceed criterion inspection results have beenresearched and been dealt with in time;7. Approve and supervise consigned inspection;8. Supervise the maintenance of workshop and equipment in order to maintain its goodworking condition;9. Ensure to finish every necessary confirmation and validation work, checking andapproving confirmation or validation scheme and report;10. Ensure to finish self-check;11. Evaluate and approve material supplier;12. Ensure all complaints related to product quality have been researched, and have beendealt with in time and accurately;13. Ensure to finish products’persistent stability review plan, provide the data ofpersistent stability review;14. Ensure to finish product quality review analysis;15. Ensure quality control and quality guarantee person have been trained by pre-jobtraining and on-job training, adjust training content according to actual demands.Article 24 Director of manufacturing management and director of quality management often have the following common responsibility:I. Audit and approve the documents of products’technology procedure, operation proceduress;II. Supervise the sanitation condition of factory;III. Ensure the key equipment have been confirmed;IV. Ensure to finish the validation of production technology;V. Ensure all related person in enterprise been trained by pre-job training and on-job training, adjust training content according to actual demands;VI. Approve and supervise consigned manufacture;VII. Ensure and monitor the storage condition of material and goods;VIII. Save the record;IX. Supervise the implement condition of this Regulation;X. Monitor the factors influence the quality of the products.Article 25 Authorized person of qualityI. Qualification:Authorized person of quality shall at least have pharmacology or related specialty undergraduate education background (or secondary professional technical title or licensed pharmacist qualification), have at least five years’ pharmaceutical goods’ manufacturing and quality management experience, have the experience of manufacturing process control and quality check work.Authorized person of quality shall have necessary professional theory knowledge, have taken part in the train about product delivering, and could take his responsibility independently.II. Main responsibility:1. Take part in the establishment of enterprise quality system, interior self-check,exterior quality audit, validate and pharmaceutical goods’bad reaction report, product recall and other quality management activities;2. Take the responsibility of product delivering, to ensure the manufacturing, checkingof every batch of delivered products are all in accordance with corresponding code, pharmaceutical goods’ registered requirements and quality standard;3. Before delivering the products, authorized person of quality must issue productdelivering audit record according to the said item 2 and bring it into batch record.Section 3 TrainingArticle 26 The enterprise shall designate department or person to take responsible for training management work, and shall have the training scheme or plan audited or approved by director of manufacture management or director of quality management. The training record shall be preserved.Article 27 All personnel related to pharmaceutical goods’manufacturing, quality shall be trained, the training content shall accommodate to the post. Except the training of theory and practice of this Regulation, responsibility, skill training about the related code, relevant post shall also be trained, and actual effect shall be periodic evaluated.Article 28 The working person in high risk operating area (such as: manufacture area of high activity, high toxic, infective, high sensitive material) shall take expert training.Section 4 Personnel SanitationArticle 29 All personnel shall take sanitation requirements training, the enterprise shall establish personnel sanitation operation proceduress, so that to reduce the pollution risk to pharmaceutical goods taken by person at its maximum.Article 30 Personnel sanitation operation procedures shall include the content related to health, sanitation practice and personnel dress. Personnel in manufacturing area and quality control area shall correctly understand related personnel sanitation operation procedures. Theenterprise shall take measures to ensure the implement of personnel sanitation operation procedures.Article 31 The enterprise shall manage personnel’s health and establish health file. The manufacture personnel contact pharmaceutical goods directly shall receive physical check, and take at least one physical check per year.Article 32 The enterprise shall take appropriate measure to avoid the person have wound in body surface, have infection disease or other person may pollute pharmaceutical goods to take the manufacture work which directly contact pharmaceutical goods.Article 33 Visiting person and untrained person shall not enter manufacture area and quality control area, if the persons need to enter in special conditions, the items of their individual sanitation, clothes changing and so on shall be instructed.Article 34 Any person enters into manufacturing area shall change clothes according to prescription. The material, style and dressing method of work clothes shall be accommodate to the work engaged and the level of air clean degree.Article 35 The person enters into clean manufacturing area shall not make up and adorn with accouterment.Article 36 Manufacturing area, storage area shall forbid smoking and having meals, forbid to store food, beverage, cigarette and individual pharmaceutical goods and other non-manufacturing goods.Article 37 Operation person shall avoid to touch the surface of pharmaceutical goods, wrapper material contact pharmaceutical goods directly and equipment by hand.Chapter 4 Workshop and EstablishmentSection 1 PrincipleArticle 38 The workshop location’s choice, design, overall arrangement, construct, reconstruct and maintenance must in accordance with the pharmaceutical goods’manufacturing requirements, which may avoid pollution, cross pollution, confusion and mistake at its maximum, and may convenient for clean, operate and maintenance.Article 39 The workshop’s location shall consider according to the workshop and manufacturing safety measures. The environment of the workshop shall reduce the pollution risk to material or products at its maximum.Article 40 The enterprise shall have tidy manufacturing environment. The floor, road surface of the workshop and transport shall not pollute the pharmaceutical goods’manufacturing. The overall arrangement of the manufacturing area, administration area, living area and assistant area shall be reasonable arranged and do not interfere each other. Stream of people and material in factory area and workshop shall reasonable.Article 41 The workshop shall take appropriate maintenance, and ensure the maintenance activity may not influence the quality of pharmaceutical goods. Clean or take necessary sterilization to workshop according to detailed written operation procedures.Article 42 The workshop shall have appropriate illumination, temperature, humidity and aeration, to ensure the quality of produced and reserved products and the performance of related equipment shall not be influenced directly or indirectly.Article 43 The design and installation of workshop, establishment shall effective prevent insect or other animal to enter in. Necessary measures shall be taken to prevent of using raticide, insecticide, smoke fumigant and so on which may pollute equipment, material, goods.Article 44 Necessary measures shall be taken to prevent unauthorized person to enter in. Manufacturing, storage and quality control area shall not be the direct gate for staffs not in this area.Article 45 Complete drawing of constructed or reconstructed workshop, public service, fixed pipeline shall be saved.Section 2 Manufacturing AreaArticle 46 In order to reduce pollution and cross pollution risk, workshop, manufacturing establishment and equipment shall reasonable designed, overall arranged and used according to the characteristic, technique process and corresponding clean level, and in accordance with the following requirements:I. Comprehensive considering the pharmaceutical goods’ characteristic, technique andintending purpose and other factors, to confirm feasibility of using workshop, manufacturing establishment and equipment together, and hing related evaluating report;II. Special and independent workshop, manufacturing establishment and equipment must be used when manufacturing special character pharmaceutical goods, such as high sensitive pharmaceutical goods (i.e. P enicillin) or biologics goods (i.e. bcg vaccine or other pharmaceutical goods prepared by active microorganism). The operating area with large quantity of dust for‎p enicillin species pharmaceutical goods shall keep comparatively negative pressure, the exhaust gas discharged to outdoor shall carry cleanse management and make it be up to the mustard. Air outlet shall be away from air inlet of other air cleanse system;III. Special establishment (i.e. independent air cleanse system) and equipment must be used when manufacturing β-lactam structure species pharmaceutical goods, sexhormone species prophylactic pharmaceutical goods, and shall be detached with other pharmaceutical goods’ manufacturing area strictly;IV. Special establishment (i.e. independent air cleanse system) and equipment shall be used when manufacturing some hormone species, cell toxicity species, high active chemical pharmaceutical goods; under special circumstance, if necessary validation shall be take before taking special protection measures, the above said pharmaceutical goods preparation could use the same establishment and equipment via manufacturing modes in different phases;V. Ventilation of air cleanse system in the above said item II, III, IV shall take cleanse management;VI. Pharmaceutical goods’ m anufacturing workshop shall not used for manufacturing non-officinal used products which may have bad influence to pharmaceutical goods’ quality.Article 47 Manufacturing area and storage area shall have enough space to ensure equipment, material, semifinished product, bulk product and finished product could storage in order, to prevent the confusion, cross pollution of different products or material, to prevent missing or mistake during the operation of manufacturing or quality control.Article 48 Air condition cleanse system shall be equipped according to pharmaceutical goods’variety, manufacturing operation’s requirement and exterior environment condition which let the manufacturing area can effective aeration, and have temperature, humidity control and atmosphere cleanse filtration, to ensure the manufacturing environment of pharmaceutical goods is in accordance with the requirements.The pressure difference between clean area and non-clean area, clean areas in different level shall not lower than 10Pascal. When necessary, appropriate pressure difference grads shall also be kept in different functional areas (operation area) with same clean level.Exposure working procedure area for oral liquid and solid preparation, chamber use pharmaceutical goods (including rectal pharmaceutical goods), surface external use pharmaceutical goods and other non-asepsis preparation manufacturing and exposureworking procedure area for wrapper material directly contact pharmaceutical goods shall equip according to the requirements of “Asepsis Pharmaceutical Goods” D level clean area in Annex. The enterprise could take appropriate microorganism monitor measures according to product s’ standard and characteristic.Article 49 Inner surface of clean area (wall, floor, sunshade) shall be slick, non-crack, narrow joint, non granule fell off, prevent stored dust, convenient for effective clean, and take sterilization when necessary.Article 50 The design and installation of every kind of pipeline, lighting establishment, place with a draught and other public establishment shall prevent having the part of not easy to clean, and shall try best to maintain outside the manufacturing area.Article 51 Sewerage shall have appropriate size and install the device of reversing flow. Try best to prevent drain in clear channel, if it is inevitably, the clear channel shall be flat so that it is convenient to clean and sterilize.Article 52 Quantify of preparation’s raw material often carry on in the metage room special designed.Article 53 Operation rooms which produce dust (such as sampling, metage, mix, package of dry material or products rooms and other operation rooms) shall keep comparatively negative pressure or take special measure, so as to prevent the diffusion of powder dust, avoid cross pollution and easy to keep clean.Article 54 Pharmaceutical goods’packaging workshop or area shall be reasonable designed and arranged, to prevent confusion or cross pollution. If there are several packaging lines in one area, isolation measures shall be taken.Article 55 Manufacturing area shall have appropriate light, the light in contact manufacturing area shall satisfy the operation requirements.Article 56 Manufacturing area could set middle control area. However, middle control operation shall not bring quality risk to pharmaceutical goods.Section 3 Storage AreaArticle 57 Storage area shall have enough space, which ensure the under-examined, qualified, disqualified, withdrew or recalled raw material, wrapper, semifinished product, bulk product and finished product and all kinds of material and products could store in order.Article 58 The design and construct of storage area shall ensure good storage condition, and have aeration and lighting establishment. Storage area shall satisfy material or products’storage condition (such as temperature, humidity, avoid of light) and safety storage requirements, and check and monitor shall be taken.Article 59 High active material or product and printing package material shall storage in safe area.Article 60 Receiving, extending and delivering area shall protect material, product out of influence of weather outside (such as rain, snow). The arrangement and establishment of receiving area shall ensure taking necessary cleaning to the received material’s outside packaging.Article 61 If the under-examined material is stored in separate isolate area, the under-examine area shall have distinct mark, and only authorized person could in and out. Disqualified, withdrew or recalled material or product shall be stored isolated.If other method is used for replacing physics isolation, this method shall have equal security.Article 62 Separate material sampling area is often set up. Air cleaning level of sampling area is the same with the manufacturing requirements. If sample is taken in other area or use other method, pollution or cross pollution shall prevent.Section 4 Quality Control AreaArticle 63 Quality control laboratory is often divided from manufacturing area. Biology examine, microorganism and radioactivity isotope laboratory shall also divided from each other.Article 64 The design of laboratory shall ensure for applying it’s intending purpose, and prevent confusion and cross pollution, enough area shall have for disposing samples, reserved samples and samples for reviewing stability and keeping the records.Article 65 When necessary, set a special instrument room to prevent static, shaking, humid or other outside factors’ disturbance to instrument with high sensitivity.Article 66 The laboratory disposing special goods such as biology samples or radioactivity samples shall in accordance with the related requirements of the country.Article 67 Experiment animal room shall be strictly divided from other area. Its design, construct shall in accordance with the related requirements of the country and have independent air disposing establishment and animal’s special channel.Section 5 Assistant AreaArticle 68 Retiring room shall not take bad influence to manufacturing area, storage area and quality control area.。